An Efficacy Study of Paliperidone for the Prevention of Relapse in Participants With Schizophrenia

NCT01662310 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

201

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Paliperidone
DRUG: Placebo

Sponsor

Janssen Research & Development, LLC